anagrelide
Drug Details
- Generic Name
- anagrelide
- Brand Names
- anagrelide
- Application Number
- ANDA209151
- Sponsor
- Torrent Pharmaceuticals Limited
- NDC Codes
- 2
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- ANAGRELIDE HYDROCHLORIDE ANHYDROUS
Indications and Usage
1 INDICATIONS AND USAGE Anagrelide capsules are indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. Anagrelide is a platelet reducing agent indicated for the treatment of thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. ( 1 )